Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...
Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...
Researchers have long suspected that the gut microbiome – the community of bacteria and other microorganisms living in the ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results